123 related articles for article (PubMed ID: 3322594)
1. Effects of carbamoylating agents on tumor metabolism.
Lea MA
Crit Rev Oncol Hematol; 1987; 7(4):329-71. PubMed ID: 3322594
[TBL] [Abstract][Full Text] [Related]
2. Chemical structure of carbamoylating groups and their relationship to bone marrow toxicity and antiglioma activity of bifunctionally alkylating and carbamoylating nitrosoureas.
Ali-Osman F; Giblin J; Berger M; Murphy MJ; Rosenblum ML
Cancer Res; 1985 Sep; 45(9):4185-91. PubMed ID: 2411398
[TBL] [Abstract][Full Text] [Related]
3. Lysis of human promyelocytic HL-60 cells by amphotericin B in combination with 2-chloroethyl-1-nitrosoureas: role of the carbamoylating activity of nitrosoureas.
Brajtburg J; Elberg S; Schechtman KB; Medoff G
Cancer Res; 1990 Jun; 50(11):3274-8. PubMed ID: 2334920
[TBL] [Abstract][Full Text] [Related]
4. A method to determine the carbamoylating potential of 1-(2-chloroethyl)-1-nitrosoureas.
Stahl W; Krauth-Siegel RL; Schirmer RH; Eisenbrand G
IARC Sci Publ; 1987; (84):191-3. PubMed ID: 2960614
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of rat liver DNA polymerase by nitrosoureas and isocyanates.
Baril BB; Baril EF; Laszlo J; Wheeler GP
Cancer Res; 1975 Jan; 35(1):1-5. PubMed ID: 162855
[TBL] [Abstract][Full Text] [Related]
6. Interference with effects of amphotericin B on Candida albicans cells by 2-chloroethyl-1-nitrosoureas.
Brajtburg J; Elberg S; Kobayashi GS; Medoff G
Antimicrob Agents Chemother; 1988 Mar; 32(3):327-30. PubMed ID: 3284460
[TBL] [Abstract][Full Text] [Related]
7. Chemosensitization of the nitrosoureas by 2-nitroimidazoles in the subcutaneous 9L tumor model: pharmacokinetic and structure-activity considerations.
Wong KH; Wallen CA; Wheeler KT
Int J Radiat Oncol Biol Phys; 1990 May; 18(5):1043-50. PubMed ID: 2140824
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of uptake of nitrosoureas by L5178Y lymphoblasts in vitro.
Begleiter A; Lam HP; Goldenberg GJ
Cancer Res; 1977 Apr; 37(4):1022-7. PubMed ID: 557367
[TBL] [Abstract][Full Text] [Related]
9. The effect of phenobarbital pretreatment on the antitumor activity of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) and 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl-1-nitrosourea (PCNU), and on the plasma pharmacokinetics and biotransformation of BCNU.
Levin VA; Stearns J; Byrd A; Finn A; Weinkam RJ
J Pharmacol Exp Ther; 1979 Jan; 208(1):1-6. PubMed ID: 759602
[TBL] [Abstract][Full Text] [Related]
10. Influence of pH on the modification of thiols by carbamoylating agents and effects on glutathione levels in normal and neoplastic cells.
Hu JJ; Dimaira MJ; Zirvi KA; Dikdan G; Lea MA
Cancer Chemother Pharmacol; 1989; 24(2):95-101. PubMed ID: 2731317
[TBL] [Abstract][Full Text] [Related]
11. Effects of carbamoylation on cell survival and DNA repair in normal human embryo cells (IMR-90) treated with various 1-(2-chloroethyl)-1-nitrosoureas.
Sariban E; Erickson LC; Kohn KW
Cancer Res; 1984 Apr; 44(4):1352-7. PubMed ID: 6704956
[TBL] [Abstract][Full Text] [Related]
12. The role of isocyanates in the toxicity of antitumour haloalkylnitrosoureas.
Gibson NW; Hickman JA
Biochem Pharmacol; 1982 Sep; 31(17):2795-800. PubMed ID: 7138575
[TBL] [Abstract][Full Text] [Related]
13. Relationship of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) pharmacokinetics of uptake, distribution, and tissue/plasma partitioning in rat organs and intracerebral tumors.
Levin VA; Kabra PA; Freeman-Dove MA
Cancer Chemother Pharmacol; 1978; 1(4):233-42. PubMed ID: 750110
[TBL] [Abstract][Full Text] [Related]
14. Action of carbamoylating agents on the uptake of metabolites in hepatomas and liver.
Lea MA; Luke A; Hu JJ; Velazquez O
Biochem Pharmacol; 1987 Sep; 36(17):2775-81. PubMed ID: 3632705
[TBL] [Abstract][Full Text] [Related]
15. Measurement of carbamoylating activity of nitrosoureas and isocyanates by a novel high-pressure liquid chromatography assay.
Brubaker WF; Zhao HP; Prusoff WH
Biochem Pharmacol; 1986 Jul; 35(14):2359-65. PubMed ID: 3729992
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of protein A24 lyase by nitrosoureas.
Markussen G; Smith-Kielland I; Dornish JM
FEBS Lett; 1984 Oct; 176(2):426-30. PubMed ID: 6489526
[TBL] [Abstract][Full Text] [Related]
17. Glutathione and N-acetylcysteine conjugates of 2-chloroethyl isocyanate. Identification as metabolites of N,N'-bis(2-chloroethyl)-N-nitrosourea in the rat and inhibitory properties toward glutathione reductase in vitro.
Davis MR; Kassahun K; Jochheim CM; Brandt KM; Baillie TA
Chem Res Toxicol; 1993; 6(3):376-83. PubMed ID: 8318660
[TBL] [Abstract][Full Text] [Related]
18. Carbamoylation of amino acid, peptides, and proteins by nitrosoureas.
Wheeler GP; Bowdon BJ; Struck RF
Cancer Res; 1975 Nov; 35(11 Pt 1):2974-84. PubMed ID: 1182691
[TBL] [Abstract][Full Text] [Related]
19. Nitrosoureas: a review of experimental antitumor activity.
Schabel FM
Cancer Treat Rep; 1976 Jun; 60(6):665-98. PubMed ID: 782694
[TBL] [Abstract][Full Text] [Related]
20. Inducible nitric oxide synthase neutralizes carbamoylating potential of 1,3-bis(2-chloroethyl)-1-nitrosourea in c6 glioma cells.
Yin JH; Yang DI; Chou H; Thompson EM; Xu J; Hsu CY
J Pharmacol Exp Ther; 2001 Apr; 297(1):308-15. PubMed ID: 11259558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
